X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9995) 9995
Magazine Article (71) 71
Newsletter (55) 55
Web Resource (36) 36
Book / eBook (24) 24
Conference Proceeding (9) 9
Dissertation (6) 6
Book Chapter (5) 5
Newspaper Article (5) 5
Streaming Video (5) 5
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9158) 9158
diphosphonates - therapeutic use (7867) 7867
science & technology (6638) 6638
life sciences & biomedicine (6505) 6505
female (5402) 5402
male (3831) 3831
bone density conservation agents - therapeutic use (3434) 3434
middle aged (2985) 2985
aged (2943) 2943
osteoporosis (2282) 2282
bisphosphonates (2035) 2035
diphosphonates - adverse effects (1872) 1872
diphosphonates - administration & dosage (1828) 1828
osteoporosis - drug therapy (1821) 1821
bone neoplasms - secondary (1619) 1619
animals (1537) 1537
adult (1500) 1500
imidazoles - therapeutic use (1499) 1499
diphosphonates - pharmacology (1428) 1428
endocrinology & metabolism (1395) 1395
diphosphonates (1374) 1374
oncology (1360) 1360
treatment outcome (1273) 1273
bone neoplasms - drug therapy (1239) 1239
risk factors (1233) 1233
bone density - drug effects (1167) 1167
aged, 80 and over (1162) 1162
bone density conservation agents - adverse effects (1122) 1122
zoledronic acid (1047) 1047
orthopedics (1038) 1038
abridged index medicus (1028) 1028
medicine & public health (1002) 1002
care and treatment (940) 940
bone density (932) 932
bone density conservation agents - administration & dosage (927) 927
drug therapy (925) 925
osteoporosis, postmenopausal - drug therapy (923) 923
bisphosphonate (879) 879
rheumatology (859) 859
bones (857) 857
fractures (812) 812
general & internal medicine (781) 781
medicine, general & internal (749) 749
research (689) 689
health aspects (681) 681
pamidronate (679) 679
antineoplastic agents - therapeutic use (661) 661
fractures, bone - prevention & control (650) 650
phosphonates (643) 643
breast neoplasms - pathology (632) 632
retrospective studies (628) 628
pharmacology & pharmacy (625) 625
breast neoplasms - drug therapy (602) 602
time factors (601) 601
cancer (599) 599
osteoporosis - prevention & control (593) 593
analysis (562) 562
dentistry (548) 548
imidazoles - administration & dosage (538) 538
breast cancer (532) 532
calcitonin - therapeutic use (526) 526
hypercalcemia - drug therapy (519) 519
drug administration schedule (510) 510
follow-up studies (503) 503
bone density conservation agents - pharmacology (497) 497
vitamin d - therapeutic use (495) 495
administration, oral (493) 493
metastasis (488) 488
child (483) 483
hypercalcemia - etiology (482) 482
endocrinology (481) 481
surgery (473) 473
osteitis deformans - drug therapy (463) 463
imidazoles - adverse effects (459) 459
imidazoles - pharmacology (448) 448
rats (447) 447
osteonecrosis - chemically induced (443) 443
adolescent (442) 442
randomized controlled trials as topic (432) 432
mice (425) 425
denosumab (419) 419
infusions, intravenous (419) 419
clinical trials as topic (412) 412
dentistry, oral surgery & medicine (412) 412
osteoporosis - complications (408) 408
bone and bones - drug effects (403) 403
absorptiometry, photon (401) 401
bone resorption - drug therapy (398) 398
dosage and administration (398) 398
prostatic neoplasms - pathology (397) 397
alendronate - therapeutic use (393) 393
radiography (393) 393
multiple myeloma - drug therapy (386) 386
osteoporosis - etiology (385) 385
etidronic acid - therapeutic use (384) 384
dose-response relationship, drug (376) 376
calcium - therapeutic use (372) 372
fractures, bone - etiology (371) 371
prostatic neoplasms - drug therapy (365) 365
internal medicine (364) 364
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (35) 35
Gerstein Science - Stacks (16) 16
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9246) 9246
Japanese (374) 374
German (269) 269
French (252) 252
Spanish (96) 96
Italian (55) 55
Chinese (42) 42
Russian (36) 36
Danish (28) 28
Dutch (27) 27
Polish (26) 26
Portuguese (24) 24
Hungarian (22) 22
Czech (18) 18
Finnish (15) 15
Croatian (11) 11
Hebrew (10) 10
Norwegian (10) 10
Swedish (9) 9
Ukrainian (6) 6
Slovak (4) 4
Arabic (2) 2
Lithuanian (2) 2
Serbian (2) 2
Georgian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer | Index Medicus
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2016, Volume 44, pp. 61 - 73
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2009, Volume 360, Issue 7, pp. 679 - 691
Journal Article
Journal of oral and maxillofacial surgery, ISSN 0278-2391, 09/2013, Volume 71, Issue 9, pp. 1532 - 1540
Purpose To investigate the efficacy and safety of zoledronic acid (ZA) combined with targeted therapy (TT). Materials and Methods A retrospective study was... 
Surgery | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Niacinamide - analogs & derivatives | Follow-Up Studies | Humans | Middle Aged | Interleukin-2 - therapeutic use | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Bevacizumab | Angiogenesis Inhibitors - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Diphosphonates - adverse effects | Everolimus | Molecular Targeted Therapy - methods | Radiography, Panoramic | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Bone Density Conservation Agents - adverse effects | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Fractures, Spontaneous - etiology | Survival Rate | Spinal Cord Compression - etiology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Carcinoma, Renal Cell - secondary | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Cohort Studies | Care and treatment | Trade and professional associations | Metastasis | Index Medicus | Abridged Index Medicus | Dentistry
Journal Article
The lancet oncology, ISSN 1470-2045, 07/2011, Volume 12, Issue 7, pp. 631 - 641
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 3, pp. 502 - 509
Abstract Background Bone metastases (BMs) are frequently present in patients with metastatic renal cell carcinoma (mRCC) and cause significant morbidity.... 
Urology | mTOR inhibitors | VEGF-targeted therapy | Renal cell carcinoma | Bisphosphonates | Bone metastases | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Niacinamide - analogs & derivatives | Prognosis | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Antineoplastic Agents - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | TOR Serine-Threonine Kinases - antagonists & inhibitors | Hypocalcemia - chemically induced | Renal Insufficiency - chemically induced | Diphosphonates - therapeutic use | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Imidazoles - therapeutic use | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Diphosphonates - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Bone Density Conservation Agents - adverse effects | Interferon-alpha - therapeutic use | Bone Density Conservation Agents - therapeutic use | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Survival Rate | Disease-Free Survival | Carcinoma, Renal Cell - secondary | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Bisphosphonate-Associated Osteonecrosis of the Jaw - etiology | Kidney Neoplasms - drug therapy | Indazoles - therapeutic use | Care and treatment | Metastasis | Carcinoma, Renal cell | Index Medicus | VEGF targeted therapy
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 1945-7197, 05/2019, Volume 104, Issue 5, pp. 1595 - 1622
Journal Article